Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nisshin Seifun Group is a prominent Japanese holding company with a diversified portfolio spanning flour milling, food products, and life sciences. Through its subsidiary, Nisshin Pharma, the group operates in the pharmaceutical and healthcare sectors, specializing in the development of active pharmaceutical ingredients (APIs), health foods, and dietary supplements. The company is a global leader in the production of Coenzyme Q10 and focuses its research on metabolic health, digestive disorders, and healthy aging. Additionally, its subsidiary Oriental Yeast Co., Ltd. provides essential biotechnology products such as enzymes and diagnostic reagents for the global scientific community. Nisshin Seifun Group integrates its long-standing expertise in fermentation and fine chemical synthesis to deliver high-quality healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nisshin Seifun Group.